Althoff, F. C., Acker, F., Koschade, S., Heinzen, S., Aguinarte, L., Rost, M., Schulte, H., Rohde, G., Demes, M., Schreiner, W., Krause, K., Grünwald, V., Serve, H., Oellerich, T., Sebastian, M. (2025). Neotrace: A multicenter phase II study of neoadjuvant sacituzumab govitecan plus zimberelimab followed by adjuvant zimberelimab with or without sacituzumab govitecan in patients with resectable non-small cell lung cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps8120